ArticleJMIR research protocols2024

Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial.

Tomoko Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.